Drug Patent Watch

AUGUST 5, 2023

In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status of reverse payment cases against pharmaceutical companies. Reverse payment cases… The post The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

BioPharma Dive

AUGUST 5, 2023

The agency turned back the companies' attempt to also win clearance for major depressive disorder, limiting its market potential.

98

98

The Guardian - Pharmaceutical Industry

AUGUST 5, 2023

A new method called ‘skeletal editing’ offers a hugely simplified way to alter matter, paving the way for world-changing innovations in personalised medicine and sustainable plastics Ask Mark Levin what excites him about his work, and the associate professor of chemistry at the University of Chicago could double as a poet. “We’re one of the only fields of science that at its core is about making things that have never existed anywhere else in the universe, and would never have existed if we didn

71

71

Drug Patent Watch

AUGUST 5, 2023

Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.… The post New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA KIT appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

BioPharma Dive

AUGUST 5, 2023

The FDA's clearance of Izervay for geographic atrophy comes as rare side effects have overshadowed the fast launch of a competing treatment from Apellis.

52

52

Drug Patent Watch

AUGUST 5, 2023

Annual Drug Patent Expirations for SIGNIFOR+LAR+KIT Signifor Lar Kit is a drug marketed by Recordati Rare and is included in one NDA. It is available from one supplier. There are… The post New patent expiration for Recordati Rare drug SIGNIFOR LAR KIT appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Drug Patent Watch

AUGUST 5, 2023

This chart shows the drugs with the most patents in Colombia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Colombia? appeared first on DrugPatentWatch - Make Better Decisions.

52

52